Cargando…
A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors
Hereditary tyrosinemia type 1 (HT1) and alkaptonuria (AKU) are inherited metabolic disorders caused by defective enzymes involved in tyrosine catabolism. Nitisinone, an ex-herbicide and member of the β-triketone family, is therapeutically applied to prevent accumulation of toxic metabolites in patie...
Autores principales: | Neuckermans, Jessie, Mertens, Alan, De Win, Dinja, Schwaneberg, Ulrich, De Kock, Joery |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775094/ https://www.ncbi.nlm.nih.gov/pubmed/31578365 http://dx.doi.org/10.1038/s41598-019-50533-1 |
Ejemplares similares
-
High-throughput quantification of ochronotic pigment formation in Escherichia coli to evaluate the potency of human 4-hydroxyphenylpyruvate dioxygenase inhibitors in multi-well format
por: Neuckermans, Jessie, et al.
Publicado: (2020) -
A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
por: Lequeue, Sien, et al.
Publicado: (2022) -
A novel enzymatic assay for the identification of 4-hydroxyphenylpyruvate dioxygenase modulators
por: Parkins, Andrew, et al.
Publicado: (2023) -
Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Fu, Ying, et al.
Publicado: (2018) -
Computer-Aided and AILDE Approaches to Design Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
por: Shi, Juan, et al.
Publicado: (2022)